TITLE

How do SSRIs help patients with irritable bowel syndrome?

AUTHOR(S)
Creed, F.
PUB. DATE
August 2006
SOURCE
Gut;Aug2006, Vol. 55 Issue 8, p1065
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the use of selective serotonin reuptake inhibitor (SSRI) for the treatment of depression patients with irritable bowel syndrome (IBS). In case of non-depressed IBS patients, placebo was found to be better than fluoxetine for improving the condition of patients. SSRI antidepressants did improve the well-being in some patients with IBS by improving their abdominal pain and bowel symptoms, but didn't show any improvement in their depression.
ACCESSION #
21843668

 

Related Articles

  • Fluoxetine effect on kidney water reabsorption. Zenaide Providello Moyses; Fausto Kigui Nakandakari; Antonio José Magaldi // Nephrology Dialysis Transplantation;Apr2008, Vol. 23 Issue 4, p1173 

    Background. The pathogenesis of hyponatraemia caused by fluoxetine(Fx) use in the treatment of depression is not well understood. It has been attributed to a SIADH, although ADH-enhanced plasma level has not yet been demonstrated in all the cases reported in humans. This experiment aimed at...

  • SSRI coverage fails to spark real debate. Norrström, Ida // New Zealand Doctor;3/12/2008, p4 

    The article reports that research on selective serotonin reuptake inhibitors (SSRIs) did not start a debate on the best use of the drugs. According to the study published in the online journal "Public Library of Science," four of the most commonly prescribed antidepressants, two of which are...

  • A Controlled Comparison of Fluoxetine and Amitriptyline in Depressed Out-patients. Young, J. P. R.; Coleman, A.; Lader, M. H. // British Journal of Psychiatry;Sep87, Vol. 151, p337 

    Fluoxetine, a selective serotonin uptake inhibitor (mean dose 73 mg each morning) was compared with amitriptyline (mean dose 122 mg at night) in a double-blind study of 64 depressed out-patients. Fifty patients completed the 6-week trial. The drugs did not differ with respect to psychiatrists'...

  • Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Siepmann, Martin; Grossmann, Jens; Mück-Weymann, Michael; Kirch, Wilhelm // Psychopharmacology;2003, Vol. 168 Issue 3, p293 

    Rationale: Though sertraline, a selective serotonin reuptake inhibitor (SSRI), causes autonomic and cognitive adverse events such as dry mouth and somnolence, there is a paucity of appropriately designed studies on the cognitive and autonomic effects of the drug in the literature. Objective: To...

  • The effect of grape seed hydroalcholic extract on testosterone concentration in fluoxetine induced oxidative stress in the mouse testise. Hajizadeh, Z.; Soleimani, M.; Najafi, B.; Zarei, L. // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p110 

    Introduction: The selective serotonin reuptake inhibitors (SSRI), including fluoxetine (FLX) are used for the treatment of depression and psychiatric disorders such as panic disorder and anxiety. Grape seed extract (GS extract) is a natural extract from the seed of grape that is rich in mono-,...

  • Ditch the pills.  // New Scientist;7/23/2005, Vol. 187 Issue 2509, p4 

    The article presents a study, which examines the role of antidepressants in tackling mental depression in human beings. The study was conducted by Joanna Moncrieff and Irving Kirsch, and published in the "British Medical Journal." They opine that antidepressants are no better than placebos and...

  • Review: Fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes. Norris, S.L. // ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p18 

    The article reports that fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes. Published and unpublished studies in any language were selected if they used pharmacotherapy as the primary strategy for weight loss in patients greater than 18 years of age with type 2...

  • Antidepressants and suicide: risk--benefit conundrums. Healy, David; Whitaker, Chris // Journal of Psychiatry & Neuroscience;Sep2003, Vol. 28 Issue 5, p331 

    Surveys available randomized controlled trials, meta-analyses of clinical trials and epidemiological studies regarding the possibility that selective serotonin reuptake inhibitor (SSRI) antidepressants might induce suicidal tendencies in patients. Dose-dependent link between SSRI and agitation...

  • Suicidality with selective serotonin reuptake inhibitors: Valid claim? Lapierre, Yvon D. // Journal of Psychiatry & Neuroscience;Sep2003, Vol. 28 Issue 5, p340 

    Surveys relevant literature addressing the epidemiological data regarding suicidal tendencies among patients receiving selective serotonin reuptake inhibitors. Issues concerning efficacy of antidepressants; Risk of depressed patient committing suicide with prescribed antidepressants; Principles...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics